Originally appeared on E! Online Jelly Roll may have just gotten the favor he needed. The ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Jelly Roll expressed his gratitude after the Tennessee Board of Parole unanimously voted to recommend the “Lonely Road” ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Introducing our In Focus on organ-on-a-chip (OoC) technology in drug development, this video explores what OoCs are, how they ...

AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and ...

Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were ...